atherosclerotic vascular disease Cardiovascular disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: a. Adult (18 years and older); b. Established atherosclerotic cardiovascular disease (i.e. coronary artery disease, ischemic heart failure, peripheral artery disease).
Exclusion criteria
Exclusion criteria: a. Current acute cardiovascular event (myocardial infarction, major stroke, acute limb ischemia in prior 2 weeks) b. Critical limb ischemia c. Terminal illness d. History of psychosis e. Current severe psychiatric disorder f. Current psychotherapy g. Non-Dutch speaking h. Cognitive impairment i. Behavioural problems that distort group meetings j. Active mindfulness/meditation or yoga practice within the past year k. Current participation in another clinical trial that possibly interferes with the study intervention or primary outcome
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life measured with SF-12 questionnaire over the twelf month study period. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Stress (PSS-10) - Depression (PHQ-9) - Anxiety (GAD-7) - Wellbeing (WHO-5) - Self-efficacy (GSES) - Fysical activity (EVS) - Nutrition (MEDAS) - Smoking (ja/nee) - Alcohol use (AUDIT-C) - Sleep (SQS) - Fatigue (VVV) - Body Mass Index (lichaamsgewicht- en lengte) - Medication adherence (SMAQ) - Cost-effectiveness (EQ-5D-5L) | — |
Countries
Netherlands